Objectives: Invasive fungal sinusitis is associated with substantial morbidity and mortality influenced by multiple factors; however, evidence regarding prognostic determinants of survival remains limited. This study aims to evaluate survival outcomes and identify prognostic factors in patients with invasive fungal sinusitis to support evidence-based treatment planning.
Methods: A retrospective study was conducted on patients with invasive fungal sinusitis treated between February 2000 and June 2018, with follow-up ending on 30 April 2021. Survival curves were analyzed using the Kaplan-Meier method and log-rank test, while Cox proportional hazards models were employed for univariate and multivariate analyses of prognostic factors.
Results: One hundred sixteen patients were diagnosed with invasive fungal sinusitis, and these patients were further classified into an acute sinusitis group (80 patients (69.0%)) and a chronic sinusitis group (36 patients (31.0%)). The overall 1-year survival rate was 49.0% (median survival time of 9.8 months). Among acute invasive fungal sinusitis patients, the 1-year survival rate and median survival time were significantly shorter than those of chronic invasive fungal sinusitis patients. Compared with Aspergillus spp., Mucor spp. appeared to be more aggressive, which resulted in a shorter 1-year survival rate and median survival time in patients with acute invasive fungal sinusitis. Conversely, chronic invasive fungal sinusitis patients with either Aspergillus spp. or Mucor spp. had nearly equivalent survival rates. Furthermore, factors predicting a poor prognosis included chemosis, altered consciousness and leukopenia.
Conclusions: Invasive fungal sinusitis still has a high mortality rate, particularly in patients with chemosis, altered consciousness and leukopenia, necessitating aggressive treatment.
扫码关注我们
求助内容:
应助结果提醒方式:
